- Home
- VATE vs IMMX Comparison
VATE vs IMMX Comparison
Compare VATE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- IMMX
- Stock Information
- Founded
- VATE 1994
- IMMX 2014
- Country
- VATE United States
- IMMX United States
- Employees
- VATE N/A
- IMMX N/A
- Industry
- VATE Metal Fabrications
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- VATE Industrials
- IMMX Health Care
- Exchange
- VATE Nasdaq
- IMMX Nasdaq
- Market Cap
- VATE 49.2M
- IMMX 51.1M
- IPO Year
- VATE 1996
- IMMX 2021
- Fundamental
- Price
- VATE $3.66
- IMMX $1.45
- Analyst Decision
- VATE
- IMMX Strong Buy
- Analyst Count
- VATE 0
- IMMX 1
- Target Price
- VATE N/A
- IMMX $7.00
- AVG Volume (30 Days)
- VATE 91.3K
- IMMX 126.0K
- Earning Date
- VATE 11-07-2024
- IMMX 11-11-2024
- Dividend Yield
- VATE N/A
- IMMX N/A
- EPS Growth
- VATE N/A
- IMMX N/A
- EPS
- VATE N/A
- IMMX N/A
- Revenue
- VATE $1,364,600,000.00
- IMMX N/A
- Revenue This Year
- VATE N/A
- IMMX N/A
- Revenue Next Year
- VATE N/A
- IMMX $200.00
- P/E Ratio
- VATE N/A
- IMMX N/A
- Revenue Growth
- VATE N/A
- IMMX N/A
- 52 Week Low
- VATE $3.25
- IMMX $1.26
- 52 Week High
- VATE $15.60
- IMMX $7.75
- Technical
- Relative Strength Index (RSI)
- VATE 43.50
- IMMX 36.71
- Support Level
- VATE $3.25
- IMMX $1.26
- Resistance Level
- VATE $4.16
- IMMX $1.94
- Average True Range (ATR)
- VATE 0.24
- IMMX 0.15
- MACD
- VATE 0.00
- IMMX -0.01
- Stochastic Oscillator
- VATE 43.55
- IMMX 30.65
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.